PCSK9 & Cardiovascular Disease Risk
November 5, 2019
Written by Maya Sankaran
Written by Maya Sankaran
Variation in serum PCSK9, cardiovascular disease risk and potential unanticipated effects of PCSK9 inhibition: A GWAS and Mendelian randomization study in the HUNT study, Norway.
Browse news by region:
- Africa (99)
- Asia (166)
- Europe (77)
- Latin America (114)
- Middle East (30)
- Multiregional (110)
- North America (44)
- Oceania (10)
